Please login to the form below
Versiti
This page shows the latest Versiti news and features for those working in and with pharma, biotech and healthcare.
Sanofi and Sobi’s once-weekly haemophilia A treatment approved by FDA
Lynn Malec, medical director of Comprehensive Center for Bleeding Disorders and associate investigator at The Versiti Blood Research Institute, said: “This approval marks an important clinical advancement for the haemophilia community
Latest news
-
Versiti launches test for vaccine-related blood clot issues
These antibodies, says Versiti, are similar to those seen in HIT – when a patient has these antibodies, alternate anticoagulation therapies must be implemented. ... Versiti's long and proud history of scientific discovery in blood clotting puts us in a
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
- FDA approves two cell-based gene therapies for sickle cell disease
- Pfizer’s Elrexfio granted EC approval for relapsed and refractory multiple myeloma
- New economic data reveals risk of disincentivising UK life sciences growth
- WHO countries hold seventh INB meeting to prevent global pandemics
- The start of a beautiful friendship
No results were found
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
- Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
